Tosi G, De Lerma Barbaro A, D'Agostino A, Valle M T, Megiovanni A M, Manca F, Caputo A, Barbanti-Brodano G, Accolla R S
Department of Clinical and Biological Sciences School of Medicine, University of Insubria, Varese, Italy.
Eur J Immunol. 2000 Jan;30(1):19-28. doi: 10.1002/1521-4141(200001)30:1<19::AID-IMMU19>3.0.CO;2-9.
Human macrophage and T cell lines were stably transfected with HIV-1 wild-type Tat or Tat mutants in the cysteine-rich region displaying trans-dominant negative effects on HIV-1 life cycle. The expression of HLA class I and class II molecules was not affected by wild-type Tat. Tat mutants, instead, profoundly down-regulated in a dose-dependent fashion the expression of class II, but not of class I, in both cell types by acting at the transcriptional level. Down-regulation was manifested on constitutive and IFN-gamma-induced class II gene expression and did not correlate with reduced transcription of the AIR-1 gene product CIITA, the major transcriptional activator of class II genes, indicating that Tat mutants did not act by inhibiting AIR-1 gene expression. Class II down-modulation had important functional implications in macrophages, as both antigen processing and presenting capacity were inhibited. These results represent the first evidence that a modified HIV-1 Tat product can act as a potent immunosuppressor by inhibiting the HLA class II expression necessary for triggering both cellular and humoral responses against pathogens. The use of these HIV-1 Tat mutants also discloses new opportunities to investigate the molecular mechanisms underlying the coordinate HLA class II gene transcription.
用人巨噬细胞和T细胞系稳定转染HIV-1野生型Tat或富含半胱氨酸区域有反式显性负效应的Tat突变体,这些突变体对HIV-1生命周期有影响。野生型Tat不影响HLA I类和II类分子的表达。相反,Tat突变体通过在转录水平起作用,以剂量依赖方式显著下调两种细胞类型中II类分子的表达,但不影响I类分子的表达。下调表现在组成型和IFN-γ诱导的II类基因表达上,且与II类基因主要转录激活因子AIR-1基因产物CIITA转录减少无关,这表明Tat突变体不是通过抑制AIR-1基因表达起作用。II类分子下调对巨噬细胞具有重要功能意义,因为抗原加工和呈递能力均受到抑制。这些结果首次证明,修饰后的HIV-1 Tat产物可通过抑制引发针对病原体的细胞和体液反应所需的HLA II类分子表达,作为一种有效的免疫抑制剂。使用这些HIV-1 Tat突变体也为研究HLA II类基因协同转录的分子机制提供了新机会。